Being overweight or obese promotes microalbuminuria and increases the risk of chronic kidney disease. This study aimed to develop a mathematical model to estimate the risk of microalbuminuria in overweight Chinese men. Urine albumin/creatinine ratio and metabolic variables were assessed in 1179 subjects, randomly divided into estimation and validation groups that were comparable with respect to all variables. Regression analysis identified body mass index, systolic blood pressure, fasting plasma glucose and blood uric acid as significant variables; these were used to develop a mathematical model for estimating the risk of microalbuminuria. The model generated a receiver-operating characteristic curve indicative of strong predictive accuracy for microalbuminuria (area under the curve, 0.81) . A probability cut-off point of 0.50 resulted in global predictive values for microalbuminuria of 86.4% and 84.1% in the validation group (n = 354) and in all subjects, respectively. This model provides a beneficial tool for identifying overweight Chinese men at risk of microalbuminuria; additional studies are required to examine the predictive ability of the model further.
Introduction
The incidence and prevalence of overweight and obesity are rapidly increasing; these conditions have become worldwide public health problems. 1 The overall prevalence of overweight and obese individuals in the adult population of China exceeds 25%. 2 Obesity plays a role in the aetiology of diabetes mellitus, hypertension and cardiovascular disease, 3 all of which increase the risk of chronic kidney disease. 4 In addition, there is growing evidence that obesity itself significantly increases the risk (and accelerates the progression) of chronic kidney disease. 5 The majority of overweight or obese subjects are unaware of their heightened risk of chronic kidney disease 6 and would, therefore, benefit from early risk screening.
Microalbuminuria is an early indicator of chronic kidney disease and is a predictor of progression to end-stage renal disease. 7 Microalbuminuria screening can assist in preventing and reversing renal damage, 8 and several international organizations recommend its use in patients with diabetes B Chen, W Xu, RJ Chen et al. Mathematical model to estimate risk of microalbuminuria or hypertension. 9, 10 Microalbuminuria screening is not currently recommended for overweight or obese people, due to lack of data regarding its cost-effectiveness. 11 The ability to identify which overweight individuals are at high risk of microalbuminuria would be helpful for the monitoring and treatment of chronic kidney disease.
Evidence indicates that metabolic disorders are present in the early stages of renal damage and are implicated in the pathogenesis of chronic kidney disease, which means that metabolic markers could be used to estimate the risk of renal damage. 12 Metabolic syndrome and its components are risk predictors of both microalbuminuria and chronic kidney disease. 13, 14 Since metabolic variables are easily assessed during routine examination, the present study aimed to develop a mathematical model using these variables, to identify overweight Chinese men with a high risk of microalbuminuria.
Subjects and methods

SUBJECTS
This prospective study recruited consecutive healthy adult male volunteers who attended the Healthcare Centre, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, China, for routine health checks between November 2009 and December 2010. Subjects were required to complete a detailed questionnaire including medical history, current medication, family history and clinical symptoms. Subjects with cardiovascular disease, chronic kidney disease, chronic liver disease or for whom there were insufficient data were excluded from the study. Eligible subjects were those with central obesity (body mass index [BMI] ≥ 24 kg/m 2 ) according to criteria for Asian populations, 15 who were free from clinically significant abnormalities and were not taking any medication known to affect renal function or lipid/glucose metabolism. The subjects were randomly divided, according to a computer-generated randomization schedule, into an estimation group (twothirds of the subjects) and, to build and validate the model, a validation group (onethird of the subjects), respectively. All study subjects were used as a second validation group.
The Ethics Committee of the Medical College of Zhejiang University, Hangzhou, China, approved the study and all subjects provided written informed consent prior to their participation.
STUDY DEFINITIONS
Microalbuminuria was defined as a urine albumin/creatinine ratio (UACR) of 30 -300 mg/g in spot morning urine samples. 16 Metabolic syndrome was defined, according to International Diabetes Federation guidelines, 17 as central obesity plus any two of the following risk factors: hypertension (systolic blood pressure [SBP] ≥ 130 mmHg and/or diastolic blood pressure [DBP] ≥ 85 mmHg); dyslipidaemia (triglyceride > 1.7 mmol/l; high-density lipoprotein cholesterol < 1.0 mmol/l in men or < 1.3 mmol/l in women); and hyperglycaemia (fasting plasma glucose [FPG] ≥ 5.6 mmol/l). Central obesity was defined as BMI ≥ 24 kg/m 2 , according to criteria for Asian populations. 15 
PHYSICAL EXAMINATIONS AND LABORATORY ANALYSES
Weight and height were measured without shoes or heavy clothing, using an anthropometric scale, and BMI was calculated. Subjects with a BMI ≥ 24 kg/m 2 were asked to collect two non-consecutive spot morning urine samples; those with B Chen, W Xu, RJ Chen et al. Mathematical model to estimate risk of microalbuminuria UACR of 30 -300 mg/g in both samples were defined as having microalbuminuria. Individuals with a UACR of 30 -300 mg/g in one urine sample only were excluded from the study. Blood pressure was measured twice using a mercury sphygmomanometer, with the subject seated for at least 10 min, and the mean of the two measurements was recorded. A fasting blood sample of 2 -3 ml was collected from a peripheral vein into a vacuum tube without anticoagulant. Blood samples were left to stand at room temperature for 30 min in order to prepare serum. Blood and urine samples were centrifuged for 5 min at 1200 g within 2 h of collection and immediately frozen at -70°C. Biochemical indices were measured by a biochemical autoanalyser (7600 Clinical Analyser, Hitachi High-Tech, Tokyo, Japan). Urine albumin was measured via rate nephelometry with a Beckman analyser (IMMAGE ® 800, Beckman Coulter, Brea, CA, USA).
STATISTICAL ANALYSES
All statistical analyses were performed using SPSS ® statistical software, version 15.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences between the validation and estimation groups were analysed with an unpaired Student's t-test for continuous variables and the χ 2 -test for categorical variables. Univariate and multivariate logistic regression analyses were used to select the final variables for the logistic regression equation, to predict the probability of microalbuminuria. Probabilities generated from the regression equation were recorded and used as new input variables for receiver operating characteristic (ROC) curve analysis. The accuracy of the microalbuminuria predictive logistic regression equation was evaluated by constructing ROC curves. The probability cut-off point for the optimal combination of sensitivity and specificity was determined by the Youden index. The equation was validated by standard diagnostic analyses of sensitivity, specificity, positive predictive value, negative predictive value and global predictive value. A two-sided value of P < 0.05 was considered to be statistically significant.
Results
A total of 1869 adult males were enrolled in the study, 617 of whom were excluded due to a BMI < 24 kg/m 2 , insufficient data, or cardiovascular or other chronic diseases. A further 62 subjects were excluded after UACR testing indicated microalbuminuria in only one urine sample, and 11 subjects with macroalbuminuria were also excluded. The final study cohort, therefore, included 1179 subjects with a mean age ± SE of 46.6 ± 0.41 years (range 20 -76 years) and a mean BMI ± SE of 26.10 ± 0.05 kg/m 2 (range 24.0 -40.2 kg/m 2 ); 18.3% (216/1179) of the subjects had microalbuminuria and 53.9% (635/1179) had metabolic syndrome. The physical and biochemical characteristics of the subjects are given in Table 1 . The estimation and validation groups were comparable with respect to all variables.
The results of the logistic regression analysis of microalbuminuria risk factors are shown in Table 2 . Microalbuminuria was significantly associated with BMI, SBP, DBP, FPG, serum triglycerides, total cholesterol, blood uric acid (BUA) and serum creatinine concentrations (P < 0.05 or P < 0.01 for all parameters). There was no association between microalbuminuria and age, blood urea nitrogen, high-or lowdensity lipoprotein cholesterol concentrations. The significant factors were used for further multivariate logistic regression analysis. 
Mathematical model to estimate risk of microalbuminuria
The results of a forward conditional multivariate stepwise logistic regression analysis of subjects in the estimation group (n = 825) are given in Table 3 . Based on the β-regression coefficient of each variable, a logistic regression equation was created as follows: where p is the probability of micro -albuminuria with independent variables of BMI, SBP, FPG and BUA. The standard probability cut-off point of 0.5 for a regression equation was used. 18 The ROC curve for the regression equation for the estimation group is shown in Fig. 1 The predictive accuracy of the mathematical model was assessed using data from the validation group and from all study subjects. The Youden index determined that a probability cut-off point of 0.14 would result in an optimal combination of sensitivity and specificity. Validation of the mathematical model with cut-off points of 0.14 and 0.50 is given in Table 4 . The sensitivity and specificity of the mathematical model at a cut-off point of 0.50 were 25.0% and 97.2% (respectively) in the validation group, and 29.6% and 96.4% in all subjects. At a cut-off point of 0.14, the sensitivity and specificity of the mathematical model were 77.8% and 61.4% (respectively) in the validation group, and 85.2% and 65.2% in all subjects. The positive predictive value and global predictive value were greatly improved at a cut-off point of 0.50 and the negative predictive value was slightly increased at a cut-off point of 0.14. The global predictive value of the model in both groups at a cut-off point of 0.50 was over 10% greater than at 0.14.
Discussion
The aim of the present study was to develop a mathematical model utilizing metabolic risk factors to estimate the risk of microalbuminuria in overweight Chinese men. The data show that it is feasible to estimate the risk of microalbuminuria by using metabolic risk factors including BMI and SBP, together with FPG and BUA concentrations, all of which can be easily obtained by physical examination and laboratory tests. To our knowledge, this is the first study to develop a mathematical equation based on metabolic risk factors for estimating the probability of microalbuminuria in overweight or obese subjects.
It is well known that obesity causes 19 Studies have reported a strong correlation between metabolic syndrome (and its components) and the risk of chronic kidney disease and microalbuminuria. 13,20 -22 The present study found that BMI, SBP and FPG predominantly contributed to the prediction of microalbuminuria by the mathematical model, but that lipids did not add value to this model. The finding that triglyceride levels were correlated with microalbuminuria in univariate but not multivariate analysis is consistent with previous research in people with type 1 diabetes. 23 Others have found that triglyceride levels are independent predictors for the progression of renal damage. 24, 25 It is possible that this discrepancy arises from inadequate statistical analysis. BUA was also included as a risk factor in the present model, since the data showed that BUA was an independent risk factor for microalbuminuria, and this is in accordance with a recent study. 26 The regression equation ROC curve represents the predictive accuracy of the mathematical model. A logistic model with high predictive accuracy generates a ROC curve that rises quickly and has a large area under the curve. If the area under the ROC curve is between 0.8 and 0.9, the model has excellent discrimination; if it is between 0.7 and 0.8, the model has acceptable discrimination; if it is < 0.7, the model has poor discrimination. 27 The mathematical model in the present study generated an area under the ROC curve of 0.81, indicating excellent discrimination, and suggesting that the model is useful for predicting the probability of microalbuminuria in overweight Chinese men. A probability cutoff point of 0.14 resulted in a balance between the percentage of individuals correctly predicted to have microalbuminuria or normalbuminuria. Lowering the cut-off point from 0.50 to 0.14 increased the percentage of correct microalbuminuria classification, but decreased the accuracy of normalbuminuria prediction. The 10% higher rate of total correct responses at a cut-off point of 0.50, compared with 0.14, indicates that 0.50 is the optimal decision threshold of this model.
Screening in the general population for UACR has been suggested, but has not been implemented in the clinical setting. 28 The mathematical model developed in the present study could provide an alternative, cost-effective method of assessing the risk of microalbuminuria. Health screening is very popular in urban Chinese populations and includes assessment of all the predictive variables required for application of the model. The model indicates the predominant risk factors for the progression of microalbuminuria in overweight Chinese men, allowing healthcare professionals to suggest lifestyle changes, such as weight loss and/or blood glucose control, while focusing more intensively on the smaller number of individuals who are at greatest risk.
There were several limitations to the present study. First, the prevalence of microalbuminuria varies between different races and genders, 22, 29 and the study subjects were all adult Chinese males; the performance of the model should be assessed in overweight females and other ethnic populations. Secondly, the lack of follow-up meant that it was not possible to determine whether the relationship between metabolic factors and microalbuminuria remained consistent over time. For this reason, individuals with one positive and one negative UACR test were excluded. Finally, the performance of the model was validated by cross-sectional data. Further studies,
